NL6411794A - - Google Patents
Info
- Publication number
- NL6411794A NL6411794A NL6411794A NL6411794A NL6411794A NL 6411794 A NL6411794 A NL 6411794A NL 6411794 A NL6411794 A NL 6411794A NL 6411794 A NL6411794 A NL 6411794A NL 6411794 A NL6411794 A NL 6411794A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1254063A CH478139A (de) | 1963-10-11 | 1963-10-11 | Verfahren zur Herstellung neuer antibiotisch wirksamer Kondensationsprodukte von Rifamycin O |
| CH1004564A CH504457A (de) | 1963-10-11 | 1964-07-31 | Verfahren zur Herstellung neuer antibiotisch wirksamer Kondensationsprodukte von Rifamycin S |
| CH1179764 | 1964-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6411794A true NL6411794A (xx) | 1965-04-12 |
Family
ID=27176360
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL130099D NL130099C (xx) | 1963-10-11 | ||
| NL6411794A NL6411794A (xx) | 1963-10-11 | 1964-10-09 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL130099D NL130099C (xx) | 1963-10-11 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3338888A (xx) |
| AT (1) | AT261805B (xx) |
| BE (1) | BE654209A (xx) |
| BR (1) | BR6463319D0 (xx) |
| CH (2) | CH478139A (xx) |
| DE (1) | DE1445634A1 (xx) |
| ES (1) | ES304831A1 (xx) |
| FI (1) | FI41029C (xx) |
| FR (4) | FR4134M (xx) |
| GB (1) | GB1081757A (xx) |
| IL (1) | IL22215A (xx) |
| NL (2) | NL6411794A (xx) |
| OA (1) | OA01187A (xx) |
| SE (2) | SE327501B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1165179A (en) * | 1966-10-25 | 1969-09-24 | Lepetit Spa | Derivatives of Rifamycin SV |
| CH536851A (de) * | 1966-10-25 | 1973-05-15 | Ciba Geigy Ag | Verfahren zur Herstellung neuer antibiotisch wirksamer Verbindungen der Rifamycinreihen |
| GB1159267A (en) * | 1966-11-03 | 1969-07-23 | Lepetit Spa | Rifamycin Derivatives |
| IT1056271B (it) * | 1975-05-20 | 1982-01-30 | Archifar Ind Chim Trentino | Prodotti derivati dalle amine aromatiche |
| IT1056272B (it) * | 1975-06-13 | 1982-01-30 | Archifar Ind Chim Trentino | Prodotti derivati dalle amine aromatiche |
| US4690919A (en) * | 1984-01-04 | 1987-09-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
| JPS63183587A (ja) * | 1985-02-05 | 1988-07-28 | Kanegafuchi Chem Ind Co Ltd | ベンゾキサジノリフアマイシン誘導体 |
| GB8608080D0 (en) * | 1986-04-02 | 1986-05-08 | Fujisawa Pharmaceutical Co | Solid dispersion composition |
| JP2544375B2 (ja) * | 1986-07-14 | 1996-10-16 | 鐘淵化学工業株式会社 | アルキル置換ベンゾキサジノリフアマイシン誘導体 |
| DE68924722T2 (de) * | 1988-03-18 | 1996-04-18 | Kanegafuchi Chemical Ind | Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel. |
| CA1304363C (en) * | 1988-11-01 | 1992-06-30 | Takehiko Yamane | 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
| EP0787494B1 (en) * | 1995-09-01 | 2004-06-09 | Kaneka Corporation | Use of rifamycin derivatives for the manufacture of a medicament for the treatment of diseases caused by infections of helicobacter pylori |
| CA2465846A1 (en) * | 2001-11-21 | 2003-06-05 | Activbiotics, Inc. | Targeted therapeutics and uses thereof |
| WO2003051299A2 (en) * | 2001-12-13 | 2003-06-26 | Activbiotics, Inc. | Sulfhydryl rifamycins and uses thereof |
| CN1894259A (zh) * | 2003-08-22 | 2007-01-10 | 活跃生物工艺学公司 | 利福霉素类似物及其应用 |
| US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
| EP1697382A4 (en) * | 2003-12-10 | 2008-11-05 | Activbiotics Inc | ANALOGUES OF RIFAMYCIN AND USES THEREOF |
| CA2550729A1 (en) * | 2003-12-23 | 2005-07-14 | Activbiotics, Inc. | Rifamycin analogs and uses thereof |
-
0
- NL NL130099D patent/NL130099C/xx active
-
1963
- 1963-10-11 CH CH1254063A patent/CH478139A/de not_active IP Right Cessation
-
1964
- 1964-07-31 CH CH1004564A patent/CH504457A/de unknown
- 1964-09-29 US US400198A patent/US3338888A/en not_active Expired - Lifetime
- 1964-10-06 DE DE19641445634 patent/DE1445634A1/de active Pending
- 1964-10-07 IL IL22215A patent/IL22215A/xx unknown
- 1964-10-08 FI FI642119A patent/FI41029C/fi active
- 1964-10-09 BR BR163319/64A patent/BR6463319D0/pt unknown
- 1964-10-09 AT AT861664A patent/AT261805B/de active
- 1964-10-09 NL NL6411794A patent/NL6411794A/xx unknown
- 1964-10-09 BE BE654209D patent/BE654209A/xx unknown
- 1964-10-09 SE SE12160/64A patent/SE327501B/xx unknown
- 1964-10-10 ES ES0304831A patent/ES304831A1/es not_active Expired
- 1964-10-12 GB GB41587/64A patent/GB1081757A/en not_active Expired
- 1964-12-31 OA OA51368A patent/OA01187A/xx unknown
-
1965
- 1965-01-07 FR FR1137A patent/FR4134M/fr not_active Expired
- 1965-01-07 FR FR1138A patent/FR4152M/fr not_active Expired
- 1965-01-07 FR FR1136A patent/FR4133M/fr not_active Expired
- 1965-01-07 FR FR1135A patent/FR4122M/fr not_active Expired
-
1968
- 1968-12-16 SE SE17190/68A patent/SE342458B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE654209A (xx) | 1965-04-09 |
| GB1081757A (en) | 1967-08-31 |
| US3338888A (en) | 1967-08-29 |
| SE327501B (xx) | 1970-08-24 |
| FI41029B (xx) | 1969-04-30 |
| IL22215A (en) | 1968-06-20 |
| FR4133M (xx) | 1966-05-02 |
| NL130099C (xx) | |
| BR6463319D0 (pt) | 1973-07-17 |
| ES304831A1 (es) | 1965-04-01 |
| CH478139A (de) | 1969-09-15 |
| FR4152M (xx) | 1966-05-09 |
| FR4122M (xx) | 1966-04-25 |
| OA01187A (fr) | 1969-01-25 |
| SE342458B (xx) | 1972-02-07 |
| DE1445634A1 (de) | 1968-12-05 |
| CH504457A (de) | 1971-03-15 |
| FI41029C (fi) | 1969-08-11 |
| FR4134M (xx) | 1966-05-02 |
| AT261805B (de) | 1968-05-10 |